"March 6, 2013 -- Insomnia symptoms in middle age are strongly linked to the later development of heart failure, a large Norwegian study shows.
The analysis, which considered more than 54,000 men and women, linked insomnia symptoms and"...
- Patient Information:
Details with Side Effects
Prescriptions for HALCION (triazolam) should be written for short-term use (7-10 days) and it should not be prescribed in quantities exceeding a 1-month supply.
DOSAGE AND ADMINISTRATION
It is important to individualize the dosage of HALCION (triazolam) Tablets for maximum beneficial effect and to help avoid significant adverse effects.
The recommended dose for most adults is 0.25 mg before retiring. A dose of 0.125 mg may be found to be sufficient for some patients (e.g., low body weight). A dose of 0.5 mg should be used only for exceptional patients who do not respond adequately to a trial of a lower dose since the risk of several adverse reactions increases with the size of the dose administered. A dose of 0.5 mg should not be exceeded.
In geriatric and/or debilitated patients the recommended dosage range is 0.125 mg to 0.25 mg. Therapy should be initiated at 0.125 mg in these groups and the 0.25 mg dose should be used only for exceptional patients who do not respond to a trial of the lower dose. A dose of 0.25 mg should not be exceeded in these patients.
As with all medications, the lowest effective dose should be used.
HALCION (triazolam) Tablets are available in the following strengths and package sizes:
0.125 mg (white, elliptical, imprinted HALCION (triazolam) 0.125): Reverse numbered
Unit Dose (100) NDC
1010 Tablet Bottles NDC 0009-0010-38
Bottles of 500 NDC 0009-0010-11
0.25 mg (powder blue, elliptical, scored, imprinted HALCION (triazolam) 0.25): Reverse numbered
Unit Dose (100)
1010 Tablet Bottles NDC 0009-0017-59
Bottles of 500 NDC 0009-0017-02
Store at controlled room temperature 20° to 25°C (68° to 77°F) [see USP].
Distributed by Pharmacia & Upjohn Company Division of Pfizer Inc. NY, NY 10017. Revised February 2008. FDA Rev date: 2/12/2008
Last reviewed on RxList: 3/10/2008
This monograph has been modified to include the generic and brand name in many instances.
Additional Halcion Information
Halcion - User Reviews
Halcion User Reviews
Now you can gain knowledge and insight about a drug treatment with Patient Discussions.
Report Problems to the Food and Drug Administration
You are encouraged to report negative side effects of prescription drugs to the FDA. Visit the FDA MedWatch website or call 1-800-FDA-1088.
Get tips for better sleep.